Henning Cammann

Berlin, BE, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Re: Scott A. Tomlins, John R. Day, Robert J. Lonigro, et al. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.04.039.

Re: Scott A. Tomlins, John R. Day, Robert J. Lonigro, et al. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.04.039.

Journal: European urology
Published: June 28, 2015

The percentage of prostate-specific antigen (PSA) isoform [-2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men aged ≤65 years.

The percentage of prostate-specific antigen (PSA) isoform [-2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men aged ≤65 years.

Journal: BJU international
Published: March 31, 2015

Hormonal 'minipuberty' influences the somatic development of boys but not of girls up to the age of 6 years.

Hormonal 'minipuberty' influences the somatic development of boys but not of girls up to the age of 6 years.

Journal: Clinical endocrinology
Published: December 19, 2014

Risk prediction models for biochemical recurrence after radical prostatectomy using prostate-specific antigen and Gleason score.

Risk prediction models for biochemical recurrence after radical prostatectomy using prostate-specific antigen and Gleason score.

Journal: Asian journal of andrology
Published: August 19, 2014

Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa).

Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa).

Journal: EJIFCC
Published: April 01, 2014

Artificial neural networks and prostate cancer--tools for diagnosis and management.

Artificial neural networks and prostate cancer--tools for diagnosis and management.

Journal: Nature reviews. Urology
Published: February 13, 2013

Comparative assessment of urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion with the serum [-2]proprostate-specific antigen-based prostate health index for detection of prostate cancer.

Comparative assessment of urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion with the serum [-2]proprostate-specific antigen-based prostate health index for detection of prostate cancer.

Journal: Clinical chemistry
Published: December 06, 2012

Multicenter evaluation of [-2]proprostate-specific antigen and the prostate health index for detecting prostate cancer.

Multicenter evaluation of [-2]proprostate-specific antigen and the prostate health index for detecting prostate cancer.

Journal: Clinical chemistry
Published: December 06, 2012

External validation of an artificial neural network and two nomograms for prostate cancer detection.

External validation of an artificial neural network and two nomograms for prostate cancer detection.

Journal: ISRN urology
Published: April 09, 2012
Showing 1-9 of 9

Last Updated: 09/26/2026